Table 4.
ART outcomes and pregnancy outcomes according to genotype sampling.
| Other mutations (n = 38) | DF508/DF508 (n = 28) | p | |
|---|---|---|---|
| Oocytes | 9.6 (± 6.5) | 11.2 (± 4.9) | NS |
| Live births | 5 (13.2%) | 5 (17.9%) | NS |
| No live births | 33 (86.8%) | 23 (82.1%) | |
| Clinical pregnancy | 8 (21.0%) | 9 (32.1%) | 0.390 NS |
| No clinical pregnancy | 30 (79.0%) | 19 (67.9%) | |
| HCG >100 UI/L | 9 (23.7%) | 10 (35.9%) | NS |
| HCG <100 UI/L | 3 (7.9%) | 0 (0%) | |
| HCG negative | 26 (68.4%) | 18 (64.3%) | |
| Number of embryos obtained | 3 (± 2.5) | 3.2 (± 2.5) | NS |
| IVF/ICSI | 13 (34.2%) | 5 (17.9%) | 0.0498 |
| IUI | 12 (31.6%) | 14 (50%) | |
| OI | 0 (0%) | 3 (10.7%) | |
| FET | 13 (34.2%) | 6 (21.4%) |
Results are expressed as mean ± SD.
Results are expressed as absolute values and as percentages in the group (column analysis).
NS, non-significant; IUI, intrauterine insemination; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; OI, ovulation induction; FET, frozen embryo transfer.